Deconstructing nucleotide binding activity of the Mdm2 RING domain.

Area of Science:

• Biochemistry
• Molecular Biology
• Oncology

Background:

• Mdm2 is a key negative regulator of the p53 tumor suppressor.
• Mdm2 possesses E3 ubiquitin ligase activity and a Really Interesting New Gene (RING) domain.
• Mdm2's RING domain preferentially binds adenine nucleotides, inducing conformational changes.

Purpose of the Study:

• To biochemically analyze the nucleotide-Mdm2 interaction.
• To investigate nucleotide binding in the homologous MdmX protein.
• To map the specific adenine nucleotide binding region within Mdm2.

Main Methods:

• Site-directed mutagenesis and protein deletion analysis of the Mdm2 RING domain.
• Biochemical assays using ATP derivatives to probe binding interactions.
• Comparative analysis of Mdm2 and MdmX nucleotide binding.

Main Results:

• MdmX exhibits similar adenine nucleotide binding affinity and specificity as Mdm2.
• The adenine nucleotide binding region in Mdm2 was mapped to residues 429-484.
• Phosphate coordination by the Mdm2 P-loop is contributory but not primary for ATP binding.
• Specific hydroxyl groups on the ribose and the adenine C6 amino group are essential for Mdm2 binding.

Conclusions:

• Adenine nucleotide binding is a conserved feature of Mdm family members, potentially impacting their functions similarly.
• The Mdm2 RING domain (residues 429-484) is critical for adenine nucleotide recognition.
• Detailed molecular interactions involving the ribose and adenine base are essential for Mdm2 nucleotide binding.